AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
50 hedge funds and large institutions have $18M invested in Accelerate Diagnostics in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 17
Holders
50
Holding in Top 10
–
Calls
$2K
Puts
$15K
Top Buyers
| 1 | +$515K | |
| 2 | +$119K | |
| 3 | +$16.2K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$16K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$1.23K |
Top Sellers
| 1 | -$778K | |
| 2 | -$356K | |
| 3 | -$281K | |
| 4 |
TC
Tejara Capital
London,
United Kingdom
|
-$254K |
| 5 |
Morgan Stanley
New York
|
-$167K |